I  The Innovation Factory

http://www.tif.net





     Office Locations:

2905 Premiere Pkwy., Suite 200
Duluth, GA 30097
Phone: 888-935-4411
Fax: 678-417-7325

 

Stages:

  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 1999, The Innovation Factory acquires or licenses technology from laboratories, inventors, and clinicians around which it builds life science ventures. The firm provides all of the necessary business services and support for medical life science start-ups. Unlike the other medical-related 'incubators' nationwide, The Innovation Factory creates, launches and manages its offspring businesses. The Innovation Factory provides the companies it founds with product invention, business formation, financing, staffing, product development, intellectual property development, prototyping, regulatory assistance, and clinical testing. A consortium of venture capital firms has allocated $30 million for The Factory's start-up enterprises. As the start-ups mature, mezzanine financing is available. The firm's venture capital consortium consists of Accuitive Medical Ventures, Versant Ventures, and SV Life Sciences. The Innovation Factory is interested in hearing ideas for therapeutic medical technologies, including the fields of cosmetic surgery, cardiovascular health, orthopedics, neuroscience, and women's health.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Anthony V. Lando Chief Operating Officer and President
    Charles E. Larsen Vice Chairman
    Cory Anderson Associate
    Dilip Paithankar Chief Technology Officer
    Gordon Wyatt Chief Financial Officer

     

    Portfolio companies include:


      Acufocus
        web link


      AqueSys
        web link


      Cellutions
        web link


      Cerebral Vascular Applications
        web link


      Colabo
        web link


      Halscion
        web link


      LipoSonix
        web link


      NeoVista
        web link


      Neuronetics
        web link


      NovaLign
        web link


      Sebacia
        web link


     

    Recent News: